- Home
- DSGN vs BKN Comparison
DSGN vs BKN Comparison
Compare DSGN & BKN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DSGN
- BKN
- Stock Information
- Founded
- DSGN 2017
- BKN 1992
- Country
- DSGN United States
- BKN United States
- Employees
- DSGN N/A
- BKN N/A
- Industry
- DSGN Biotechnology: Pharmaceutical Preparations
- BKN Trusts Except Educational Religious and Charitable
- Sector
- DSGN Health Care
- BKN Finance
- Exchange
- DSGN Nasdaq
- BKN Nasdaq
- Market Cap
- DSGN 208.9M
- BKN 196.1M
- IPO Year
- DSGN 2021
- BKN N/A
- Fundamental
- Price
- DSGN $5.74
- BKN $11.31
- Analyst Decision
- DSGN
- BKN
- Analyst Count
- DSGN 0
- BKN 0
- Target Price
- DSGN N/A
- BKN N/A
- AVG Volume (30 Days)
- DSGN 201.9K
- BKN 55.5K
- Earning Date
- DSGN 11-06-2025
- BKN 01-01-0001
- Dividend Yield
- DSGN N/A
- BKN 4.38%
- EPS Growth
- DSGN N/A
- BKN N/A
- EPS
- DSGN N/A
- BKN N/A
- Revenue
- DSGN N/A
- BKN N/A
- Revenue This Year
- DSGN N/A
- BKN N/A
- Revenue Next Year
- DSGN N/A
- BKN N/A
- P/E Ratio
- DSGN N/A
- BKN N/A
- Revenue Growth
- DSGN N/A
- BKN N/A
- 52 Week Low
- DSGN $2.60
- BKN $9.57
- 52 Week High
- DSGN $7.77
- BKN $12.69
- Technical
- Relative Strength Index (RSI)
- DSGN 43.44
- BKN 53.78
- Support Level
- DSGN $6.01
- BKN $11.30
- Resistance Level
- DSGN $7.21
- BKN $11.45
- Average True Range (ATR)
- DSGN 0.62
- BKN 0.07
- MACD
- DSGN -0.12
- BKN -0.01
- Stochastic Oscillator
- DSGN 3.65
- BKN 47.06
About DSGN Design Therapeutics Inc.
Design Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the research and development of GeneTACTM molecules, which are a novel class of small-molecule gene-targeted chimera therapeutic candidates designed to be disease-modifying by addressing the underlying cause of diseases caused by inherited nucleotide repeat expansion mutations. The Company's product candidate is in Friedreich ataxia (FA), its second product candidate is in Fuchs endothelial corneal dystrophy (FECD), and it is also advancing its GeneTACTM program to address other serious nucleotide repeat-driven monogenic diseases.
About BKN BlackRock Investment Quality Municipal Trust Inc. (The)
Blackrock Investment Quality Municipal Trust, Inc. is a closed-end management investment fund with the investment objective to provide high current income exempt from regular U.S. federal income tax consistent with the preservation of capital.